Yaping Chu1, Aron S Buchman1,2, C Warren Olanow3, Jeffrey H Kordower1,4. 1. Department of Neurological Sciences, Rush University Medical Center, Chicago, IL. 2. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL. 3. Clintrex, Rye, NY. 4. Van Andel Research Institute, Grand Rapids, MI.
Abstract
OBJECTIVE: Understanding the pathological changes underlying mild motor features of the eldery and defining a patient population with prodromal Parkinson disease (PD) are of great clinical importance. It remains unclear, however, how to accurately and specifically diagnose prodromal PD. We examined whether older adults with minimal parkinsonian motor features have nigrostriatal degeneration and α-synuclein pathology consistent with prodromal PD. METHODS: Brain sections were obtained from older adults with a clinical diagnosis of PD (n = 21) and without a clinical diagnosis of PD (n = 27) who underwent motor examination proximate to death. Cases without PD were further dichotomized into no motor deficit (n = 9) or minimal motor features (n = 18) groups using a modified Unified Parkinson's Disease Rating Scale. We performed quantitative unbiased stereological analyses of dopaminergic neurons/terminals and α-synuclein accumulation in the nigrostriatal system. RESULTS: In all subjects with minimal motor features, there were significant reductions in dopaminergic neurons and terminals in the substantia nigra and putamen that were intermediate between subjects with no motor deficit and PD. Phosphorylated α-synuclein inclusions were observed in the substantia nigra that were of similar density to what was seen in PD. Furthermore, there was greater Lewy neuritic pathology in the putamen relative to PD patients. Lastly, neurons with α-synuclein inclusions displayed reductions in tyrosine hydroxylase expression that were comparable in subjects with both minimal motor features and PD. INTERPRETATION: Minimal motor features in older adults may represent prodromal PD and identify at-risk individuals for testing putative neuroprotective interventions that could slow or prevent PD progression. Ann Neurol 2018;83:562-574.
OBJECTIVE: Understanding the pathological changes underlying mild motor features of the eldery and defining a patient population with prodromal Parkinson disease (PD) are of great clinical importance. It remains unclear, however, how to accurately and specifically diagnose prodromal PD. We examined whether older adults with minimal parkinsonian motor features have nigrostriatal degeneration and α-synuclein pathology consistent with prodromal PD. METHODS: Brain sections were obtained from older adults with a clinical diagnosis of PD (n = 21) and without a clinical diagnosis of PD (n = 27) who underwent motor examination proximate to death. Cases without PD were further dichotomized into no motor deficit (n = 9) or minimal motor features (n = 18) groups using a modified Unified Parkinson's Disease Rating Scale. We performed quantitative unbiased stereological analyses of dopaminergic neurons/terminals and α-synuclein accumulation in the nigrostriatal system. RESULTS: In all subjects with minimal motor features, there were significant reductions in dopaminergic neurons and terminals in the substantia nigra and putamen that were intermediate between subjects with no motor deficit and PD. Phosphorylated α-synuclein inclusions were observed in the substantia nigra that were of similar density to what was seen in PD. Furthermore, there was greater Lewy neuritic pathology in the putamen relative to PDpatients. Lastly, neurons with α-synuclein inclusions displayed reductions in tyrosine hydroxylase expression that were comparable in subjects with both minimal motor features and PD. INTERPRETATION: Minimal motor features in older adults may represent prodromal PD and identify at-risk individuals for testing putative neuroprotective interventions that could slow or prevent PD progression. Ann Neurol 2018;83:562-574.
Authors: Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl Journal: Mov Disord Date: 2015-10 Impact factor: 10.338
Authors: William J Marks; Raymond T Bartus; Joao Siffert; Charles S Davis; Andres Lozano; Nicholas Boulis; Jerrold Vitek; Mark Stacy; Dennis Turner; Leonard Verhagen; Roy Bakay; Raymond Watts; Barton Guthrie; Joseph Jankovic; Richard Simpson; Michele Tagliati; Ron Alterman; Matthew Stern; Gordon Baltuch; Philip A Starr; Paul S Larson; Jill L Ostrem; John Nutt; Karl Kieburtz; Jeffrey H Kordower; C Warren Olanow Journal: Lancet Neurol Date: 2010-10-20 Impact factor: 44.182
Authors: Aron S Buchman; Joshua M Shulman; Sukriti Nag; Sue E Leurgans; Steven E Arnold; Martha C Morris; Julie A Schneider; David A Bennett Journal: Ann Neurol Date: 2012-02 Impact factor: 10.422
Authors: Aron S Buchman; Sue E Leurgans; Lei Yu; Robert S Wilson; Andrew S Lim; Bryan D James; Joshua M Shulman; David A Bennett Journal: Neurology Date: 2016-08-03 Impact factor: 9.910
Authors: Seok Jong Chung; Yang Hyun Lee; Han Soo Yoo; Young H Sohn; Byoung Seok Ye; Jungho Cha; Phil Hyu Lee Journal: Eur J Nucl Med Mol Imaging Date: 2019-04-12 Impact factor: 9.236
Authors: Yaping Chu; Scott Muller; Adriana Tavares; Olivier Barret; David Alagille; John Seibyl; Gilles Tamagnan; Ken Marek; Kelvin C Luk; John Q Trojanowski; Virginia M Y Lee; Jeffrey H Kordower Journal: Brain Date: 2019-11-01 Impact factor: 13.501
Authors: Alejandra Camacho-Soto; Anat Gross; Susan Searles Nielsen; Anna N Miller; Mark N Warden; Amber Salter; Brad A Racette Journal: Neurology Date: 2020-04-28 Impact factor: 9.910
Authors: Meagan Bailey; Lisa M Shulman; Diane Ryan; Bichun Ouyang; Joshua M Shulman; Aron S Buchman; David A Bennett; Lisa L Barnes; Deborah A Hall Journal: J Gerontol A Biol Sci Med Sci Date: 2021-06-14 Impact factor: 6.053
Authors: Diptaman Chatterjee; Mansi Bhatt; David Butler; Erwin De Genst; Christopher M Dobson; Anne Messer; Jeffrey H Kordower Journal: NPJ Parkinsons Dis Date: 2018-08-22
Authors: Alexander Balck; Max Borsche; Meike Kasten; Katja Lohmann; Philip Seibler; Norbert Brüggemann; Christine Klein Journal: Ann Clin Transl Neurol Date: 2019-05-02 Impact factor: 4.511